Updates in Medicine: From evidence to everyday practice.
Selected medical research, guidelines and clinical reviews—translated into clear, practical updates for doctors and medical professionals.
200,000+followers across our medical community
Once-Weekly Mosnodenvir Prevents Dengue Infection in 83% of Participants in Early Human Challenge Trial
Antiplatelet Management in Coronary Syndromes: 2026 AHA Scientific Statement
Preventive Care in Cirrhosis: 2026 ACG Clinical Guideline – A Practical Summary
The 2026 Nobel Prize in Physiology or Medicine: How Light Became a Switch for the Brain
2026 ADA/EASD Type 2 Diabetes Management Update: From Glucose Control to Early Organ Protection
Latest Guidelines
Browse by specialityRecent clinical guidance. Select a title to open the original source.
- KDIGO 2027 CKD Drug Therapy — Public Review Draft (not final)
KDIGO
- Management of Fungal Nail Infection
BAD
- Management of Primary Biliary Cholangitis
AASLD/AGA
- Imaging of Chronic Subdural Haematoma
ASFNR
- Management of Hidradenitis Suppurativa
AAD/HSF
- Exercise Prescriptions for Cardiovascular Health in Adults
ACC
- Health Literacy and Communication in Stroke Care
AHA
- Management of Myelofibrosis in Adults
ASH
- Multidisciplinary Antiplatelet Management in Coronary Syndromes
AHA
- Systemic Juvenile Idiopathic Arthritis
PAFLAR
Latest Research
Browse by specialitySelected medical research. Click a headline to read the original journal article.
- Retatrutide reduces obstructive sleep apnoea severity in adults with overweight or obesity
NEJM
Two phase 3 OSA cohorts, 691 participants. At 80 weeks, 9–12 mg reduced AHI by roughly 14–24 events/hour more than placebo. Includes the previously reported TRIUMPH-1 OSA cohort; gastrointestinal adverse events were most common. First-online metadata: 20 October; the article Notes section gives 21 October. - Semaglutide shows no unexpected safety signal across kidney-function subgroups in FLOW
Kidney International
Prespecified descriptive safety analysis, 3,533 participants. Fewer serious adverse events across eGFR groups; gastrointestinal discontinuations were more frequent than with placebo. - Higher tidal volume relative to predicted body weight is associated with NIV failure
Critical Care Medicine
Meta-analysis of 11 observational studies, 1,136 patients. Evidence concerns prognosis, mainly hypoxaemic respiratory failure; it does not prove that reducing tidal volume improves outcomes. - Shorter diabetes duration and no insulin use predict remission after metabolic surgery
Diabetes Care
ARMMS-T2D follow-up, 262 patients. Ever achieving remission over median 11 years: 58% after surgery versus 3% with medical/lifestyle care; this is not sustained remission in everyone. - Point-of-care high-sensitivity troponin shortens emergency-department stays
Circulation
ICare-FASTER cluster RCT, 59,980 presentations. Adjusted stay fell by 47 minutes; 30-day MI or cardiac death was 0.39% in both groups. - Seven-day continuous ECG detects more clinically important arrhythmias in children
JAMA Pediatrics
Single-centre study, 435 children. Major arrhythmia detection 6.2% versus 2.3% with 24-hour Holter or event recording; not a randomised outcomes trial. - A long-form troponin T assay improves myocardial infarction discrimination in kidney dysfunction
Nephrology Dialysis Transplantation
Prospective diagnostic study of 1,811 patients with elevated conventional high-sensitivity troponin T. Greatest advantage at low eGFR; further validation needed.
Most Read
Preventive Care in Cirrhosis: 2026 ACG Clinical Guideline – A Practical Summary
2026 ADA/EASD Type 2 Diabetes Management Update: From Glucose Control to Early Organ Protection
Retatrutide: First-in-Class Triple Agonism with Benefits Beyond Weight Reduction
Diuretics in acute heart failure with rising creatinine: continue, reduce or stop?
2026 TTP Diagnostic Pathway: A Practical Approach to Suspected Thrombotic Thrombocytopenic Purpura
Lipoprotein(a) in Practice: Who to Test, How to Interpret It, and What to Do When It Is High
The 2026 ESC Heart Failure Guideline: From Diagnosis to Advanced Heart Failure
The 2026 Nobel Prize in Physiology or Medicine: How Light Became a Switch for the Brain
LDL-C Management in 2026: A Practical Guide to Risk-Based Targets and Treatment
SBP Prophylaxis in Cirrhosis: Who Needs Primary vs Secondary Prevention — and When Should It Be Stopped?
Events & Opportunities
Postgraduate Course: Advancing Hepatology—Breakthroughs Shaping Tomorrow’s Care
- Date
- 5 November 2026
- Organiser
- American Association for the Study of Liver Diseases
- Format
- In person
Reach the right medical professionals
Share relevant clinical, academic and healthcare career opportunities with the Updates in Medicine community.
About the platform
From evidence
to everyday
practice.
Updates in Medicine selects important research, guidelines and clinical reviews—translating them into clear, practical updates for doctors and medical professionals.
Explore our approach